Table 3.

Univariate and multivariable analyses for liver fibrosis and cirrhosis.

	Fibrosis (n = 220)				Cirrhosis (n = 292)
	Univariate Analysis		Multivariate Analysis		Univariate Analysis		Multivariate Analysis
	OR (95% CI)	P Value	OR (95% CI)	P Value	OR (95% CI)	P Value	OR (95% CI)	P Value
Age (yr)	1.031(1.009–1.054)	0.007	1.018(0.983–1.054)	0.330	1.030(1.009–1.053)	0.006	0.987(0.949–1.028)	0.534
Gender (n)	1.063(0.619–1.826)	0.825		NA	2.157(1.175–3.958)	0.013	2.396(0.965–5.951)	0.060
ALT (U/L)	0.996(0.992–1.000)	0.052		NA	1.000(0.998–1.003)	0.727		NA
AST (U/L)	0.999(0.993–1.004)	0.617		NA	1.006(1.002–1.010)	0.007	0.994(0.968–1.021)	0.682
PLT (× 109/L)	0.983(0.978–0.989)	< 0.0001	0.993(0.985–1.002)	0.124	0.972(0.965–0.979)	< 0.0001	0.985(0.975–0.996)	0.008
APRI score	1.312(0.947–1.818)	0.103		NA	2.120(1.604–2.802)	< 0.0001	0.927(0.368–2.335)	0.872
FIB-4 index	2.373(1.625–3.465)	< 0.0001	1.646(1.014–2.672)	0.044	1.772(1.494–2.102)	< 0.0001	1.533(1.019–2.306)	0.040
TET3 (ng/mL)	1.007(1.004–1.009)	< 0.0001	1.006(1.004–1.008)	< 0.0001	1.002(1.002–1.003)	< 0.0001	1.002(1.001–1.003)	< 0.0001

NA: not adopted.